Belmont, MA, United States of America

Zhaoxia Yang

USPTO Granted Patents = 8 

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Zhaoxia Yang: Innovator in BAF-Related Disorders

Introduction

Zhaoxia Yang is a prominent inventor based in Belmont, MA (US). He has made significant contributions to the field of medical research, particularly in the treatment of BAF-related disorders. With a total of 8 patents to his name, Yang's work has the potential to impact the lives of many individuals suffering from various health conditions.

Latest Patents

Yang's latest patents focus on innovative methods and compositions for treating BAF-related disorders, including cancers and viral infections. His inventions include compounds that offer new therapeutic options for these challenging medical issues. The emphasis on both methods and compositions highlights his commitment to advancing treatment possibilities in this critical area of healthcare.

Career Highlights

Throughout his career, Zhaoxia Yang has been associated with Foghorn Therapeutics Inc., where he has played a vital role in research and development. His expertise in the field has led to groundbreaking discoveries that are paving the way for new treatment modalities. Yang's dedication to innovation is evident in his extensive patent portfolio.

Collaborations

Yang has collaborated with notable colleagues, including Sabine K Ruppel and Jason T Lowe. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to more effective solutions for BAF-related disorders.

Conclusion

Zhaoxia Yang is a distinguished inventor whose work in the treatment of BAF-related disorders is making a significant impact. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…